These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22687305)

  • 1. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.
    Mansour AM; Arevalo JF; Fardeau C; Hrisomalos EN; Chan WM; Lai TY; Ziemssen F; Ness T; Sibai AM; Mackensen F; Wolf A; Hrisomalos N; Heiligenhaus A; Spital G; Jo Y; Gomi F; Ikuno Y; Akesbi J; LeHoang P; Adan A; Mahendradas P; Khairallah M; Guthoff R; Ghandour B; Küçükerdönmez C; Kurup SK
    Can J Ophthalmol; 2012 Jun; 47(3):269-74. PubMed ID: 22687305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.
    Mansour AM; Arevalo JF; Ziemssen F; Mehio-Sibai A; Mackensen F; Adan A; Chan WM; Ness T; Banker AS; Dodwell D; Chau Tran TH; Fardeau C; Lehoang P; Mahendradas P; Berrocal M; Tabbarah Z; Hrisomalos N; Hrisomalos F; Al-Salem K; Guthoff R
    Am J Ophthalmol; 2009 Aug; 148(2):310-316.e2. PubMed ID: 19427992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab in inflammatory ocular neovascularization.
    Mansour AM; Mackensen F; Arevalo JF; Ziemssen F; Mahendradas P; Mehio-Sibai A; Hrisomalos N; Lai TY; Dodwell D; Chan WM; Ness T; Banker AS; Pai SA; Berrocal MH; Tohme R; Heiligenhaus A; Bashshur ZF; Khairallah M; Salem KM; Hrisomalos FN; Wood MH; Heriot W; Adan A; Kumar A; Lim L; Hall A; Becker M
    Am J Ophthalmol; 2008 Sep; 146(3):410-416. PubMed ID: 18619571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for juxtafoveal choroidal neovascularization secondary to multifocal choroiditis.
    Parodi MB; Iacono P; Mansour A; Benedetto Ud; Knutsson KA; Bandello F; Ziemssen F; Ness T; Dodwell D
    Retina; 2013 May; 33(5):953-6. PubMed ID: 23503338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
    Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
    Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
    Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
    Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results.
    Julián K; Terrada C; Fardeau C; Cassoux N; Français C; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2011 Mar; 89(2):179-84. PubMed ID: 21348964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP
    Retina; 2010; 30(10):1609-15. PubMed ID: 20856171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
    Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN
    Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis.
    Parodi MB; Iacono P; La Spina C; Knutsson KA; Mansour A; Arevalo JF; Bandello F
    Br J Ophthalmol; 2014 Apr; 98(4):519-22. PubMed ID: 24414400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
    Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
    Sudhalkar A; Yogi R; Chhablani J
    Retina; 2015 Jul; 35(7):1368-74. PubMed ID: 25830696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and anatomic response of the retina and the choroid to intravitreal bevacizumab for macular edema.
    Forte R; Cennamo G; Breve MA; Vecchio EC; de Crecchio G
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):69-75. PubMed ID: 22059904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy.
    Cornish KS; Williams GJ; Gavin MP; Imrie FR
    Eur J Ophthalmol; 2011; 21(4):440-5. PubMed ID: 21188681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.